Clinical Trials Browser

Phase 2 × NIH × Protein Subunit Vaccines × Clear all

NCT00706992 2015-10-28

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Phase 2 Terminated

50 enrolled 13 charts

Melanoma

NCT00109811 2013-01-23

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00005949 2013-01-16

Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma

Phase 2 Completed

Melanoma